Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Pomanda estimates the enterprise value of ALLIANCE PHARMA PLC at £578.5m based on a Turnover of £180.7m and 3.2x industry multiple (adjusted for size and gross margin).
alliance pharma plcEstimated Valuation
£0
Pomanda estimates the enterprise value of ALLIANCE PHARMA PLC at £0 based on an EBITDA of £-28.1m and a 13.38x industry multiple (adjusted for size and gross margin).
alliance pharma plcEstimated Valuation
£284.3m
Pomanda estimates the enterprise value of ALLIANCE PHARMA PLC at £284.3m based on Net Assets of £217.9m and 1.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Alliance Pharma PlcOverview
Alliance Pharma Plc is a live company located in chippenham, SN15 2BB with a Companies House number of 04241478. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in June 2001, it's largest shareholder is
undisclosed
with a 100% stake. Alliance Pharma Plc is a mature,
mega sized company, Pomanda has estimated its turnover at
£180.7m with
healthy
growth in recent years.
Pomanda's financial health check has awarded Alliance Pharma Plc a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
7 Strong
1 Regular
4 Weak
Size
annual sales of £180.7m, make it larger than the average company (£18.9m)
£180.7m - Alliance Pharma Plc
£18.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 12%, show it is growing at a similar rate (10.5%)
12% - Alliance Pharma Plc
10.5% - Industry AVG
Production
with a gross margin of 58.1%, this company has a lower cost of product (36.3%)
58.1% - Alliance Pharma Plc
36.3% - Industry AVG
Profitability
an operating margin of -21.3% make it less profitable than the average company (4.5%)
-21.3% - Alliance Pharma Plc
4.5% - Industry AVG
Employees
with 284 employees, this is above the industry average (104)
284 - Alliance Pharma Plc
104 - Industry AVG
Pay Structure
on an average salary of £90.2k, the company has a higher pay structure (£44.7k)
£90.2k - Alliance Pharma Plc
£44.7k - Industry AVG
Efficiency
resulting in sales per employee of £636.2k, this is more efficient (£191k)
£636.2k - Alliance Pharma Plc
£191k - Industry AVG
Debtor Days
it gets paid by customers after 99 days, this is later than average (45 days)
99 days - Alliance Pharma Plc
45 days - Industry AVG
Creditor Days
its suppliers are paid after 87 days, this is slower than average (44 days)
87 days - Alliance Pharma Plc
44 days - Industry AVG
Stock Days
it holds stock equivalent to 124 days, this is more than average (40 days)
124 days - Alliance Pharma Plc
40 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 28 weeks, this is more cash available to meet short term requirements (14 weeks)
28 weeks - Alliance Pharma Plc
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 47.5%, this is a lower level of debt than the average (69.6%)
47.5% - Alliance Pharma Plc
69.6% - Industry AVG
ALLIANCE PHARMA PLC financials
EXPORT
Alliance Pharma Plc's latest turnover from December 2023 is £180.7 million and the company has net assets of £217.9 million. According to their latest financial statements, Alliance Pharma Plc has 284 employees and maintains cash reserves of £22.4 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
180,680,000
167,416,000
163,207,000
129,801,000
135,637,000
118,208,000
101,644,000
97,492,000
48,344,000
43,536,000
45,275,000
44,897,000
45,957,000
49,881,000
31,237,000
Other Income Or Grants
Cost Of Sales
75,661,000
65,733,000
53,757,000
46,985,000
49,561,000
45,560,000
42,496,000
42,643,000
19,614,000
18,493,000
17,944,000
19,779,000
21,469,000
19,483,000
13,127,000
Gross Profit
105,019,000
101,683,000
109,450,000
82,816,000
86,076,000
72,648,000
59,148,000
54,849,000
28,730,000
25,043,000
27,331,000
25,118,000
24,488,000
30,398,000
18,110,000
Admin Expenses
143,461,000
119,372,000
87,875,000
66,500,000
50,447,000
48,981,000
28,971,000
29,239,000
11,768,000
13,872,000
14,019,000
12,798,000
12,149,000
13,424,000
6,853,000
Operating Profit
-38,442,000
-17,689,000
21,575,000
16,316,000
35,629,000
23,667,000
30,177,000
25,610,000
16,962,000
11,171,000
13,312,000
12,320,000
12,339,000
16,974,000
11,257,000
Interest Payable
10,471,000
5,433,000
3,646,000
3,300,000
4,576,000
3,457,000
3,144,000
3,355,000
1,971,000
1,090,000
1,281,000
1,541,000
1,600,000
2,410,000
2,834,000
Interest Receivable
113,000
72,000
228,000
23,000
627,000
104,000
111,000
139,000
48,000
50,000
2,000
7,000
2,000
Pre-Tax Profit
-48,800,000
-23,050,000
18,157,000
13,016,000
31,076,000
22,803,000
28,289,000
22,219,000
15,182,000
10,157,000
12,009,000
10,809,000
10,712,000
12,872,000
5,740,000
Tax
15,664,000
1,842,000
-10,838,000
-4,989,000
-6,066,000
-4,447,000
541,000
-4,127,000
-2,490,000
-1,772,000
-2,425,000
-2,119,000
-2,076,000
-3,918,000
-1,633,000
Profit After Tax
-33,136,000
-21,208,000
7,319,000
8,027,000
25,010,000
18,356,000
28,830,000
18,092,000
12,692,000
8,385,000
9,584,000
8,690,000
8,636,000
8,954,000
4,107,000
Dividends Paid
9,592,000
9,116,000
8,604,000
7,596,000
6,346,000
5,729,000
5,152,000
2,643,000
2,398,000
2,040,000
1,803,000
1,359,000
1,069,000
Retained Profit
-42,728,000
-30,324,000
-1,285,000
8,027,000
17,414,000
12,010,000
23,101,000
12,940,000
10,049,000
5,987,000
7,544,000
6,887,000
7,277,000
7,885,000
4,107,000
Employee Costs
25,613,000
22,254,000
24,519,000
20,763,000
20,503,000
17,963,000
15,421,000
12,196,000
8,400,000
5,995,000
6,269,000
5,529,000
4,756,000
4,025,000
2,937,000
Number Of Employees
284
249
255
221
219
210
182
143
86
74
72
63
59
48
34
EBITDA*
-28,116,000
-6,929,000
31,680,000
30,126,000
37,304,000
25,213,000
31,564,000
26,039,000
17,400,000
12,588,000
14,000,000
13,071,000
13,337,000
17,964,000
11,381,000
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
15,498,000
14,417,000
12,620,000
20,881,000
15,748,000
9,619,000
11,033,000
6,621,000
5,018,000
3,323,000
3,030,000
564,000
765,000
888,000
132,000
Intangible Assets
299,978,000
393,372,000
413,744,000
412,872,000
328,660,000
335,243,000
278,623,000
264,833,000
249,832,000
88,875,000
87,111,000
79,890,000
66,130,000
60,287,000
44,935,000
Investments & Other
77,000
17,000
1,808,000
2,945,000
1,464,000
2,927,000
2,733,000
2,438,000
Debtors (Due After 1 year)
5,052,000
4,705,000
3,897,000
2,821,000
2,386,000
1,462,000
Total Fixed Assets
310,828,000
403,672,000
422,467,000
431,614,000
344,408,000
344,862,000
289,656,000
271,454,000
254,850,000
92,198,000
90,141,000
80,454,000
66,895,000
61,175,000
45,067,000
Stock & work in progress
25,711,000
24,286,000
21,075,000
22,917,000
19,089,000
18,706,000
14,248,000
15,356,000
12,910,000
5,914,000
5,468,000
5,393,000
5,652,000
4,544,000
2,972,000
Trade Debtors
49,371,000
44,764,000
23,929,000
19,834,000
23,987,000
26,849,000
17,347,000
26,706,000
8,783,000
6,645,000
9,131,000
9,583,000
8,152,000
9,139,000
7,226,000
Group Debtors
2,124,000
1,260,000
555,000
170,000
30,000
57,000
114,000
Misc Debtors
5,345,000
4,560,000
6,892,000
5,280,000
7,005,000
2,299,000
4,224,000
1,587,000
1,122,000
1,340,000
562,000
478,000
494,000
317,000
Cash
22,436,000
31,714,000
29,061,000
28,898,000
17,830,000
10,893,000
11,184,000
7,221,000
3,229,000
1,434,000
687,000
4,634,000
1,079,000
1,989,000
1,104,000
misc current assets
1,232,000
157,000
64,000
310,000
697,000
total current assets
104,095,000
105,481,000
81,021,000
77,239,000
68,608,000
58,747,000
49,127,000
49,283,000
27,769,000
15,670,000
16,796,000
20,172,000
15,391,000
16,223,000
11,733,000
total assets
414,923,000
509,153,000
503,488,000
508,853,000
413,016,000
403,609,000
338,783,000
320,737,000
282,619,000
107,868,000
106,937,000
100,626,000
82,286,000
77,398,000
56,800,000
Bank overdraft
68,035,000
683,000
Bank loan
41,719,000
25,782,000
15,776,000
2,895,000
2,895,000
6,250,000
4,250,000
4,000,000
3,114,000
Trade Creditors
18,225,000
18,567,000
8,341,000
11,275,000
6,970,000
8,978,000
6,662,000
5,655,000
1,153,000
1,693,000
1,118,000
902,000
1,194,000
3,799,000
1,690,000
Group/Directors Accounts
other short term finances
413,000
15,000
500,000
732,000
3,022,000
5,026,000
hp & lease commitments
768,000
613,000
456,000
964,000
1,025,000
447,000
579,000
1,000
other current liabilities
21,164,000
27,842,000
31,780,000
17,932,000
16,211,000
13,763,000
11,697,000
15,818,000
9,800,000
6,827,000
10,882,000
14,893,000
8,415,000
9,178,000
5,960,000
total current liabilities
40,570,000
47,022,000
40,577,000
30,186,000
24,206,000
91,723,000
61,389,000
50,277,000
31,755,000
11,415,000
14,895,000
22,045,000
13,859,000
16,978,000
11,447,000
loans
229,063,000
267,488,000
236,972,000
276,656,000
161,690,000
61,283,000
83,623,000
115,492,000
118,056,000
38,599,000
41,762,000
40,450,000
34,910,000
34,835,000
53,535,000
hp & lease commitments
2,426,000
1,997,000
1,972,000
Accruals and Deferred Income
other liabilities
3,200,000
3,415,000
211,000
3,200,000
3,975,000
380,000
5,523,000
1,817,000
1,496,000
20,000
40,000
60,000
80,000
provisions
75,726,000
118,910,000
123,456,000
112,362,000
59,620,000
57,326,000
53,840,000
62,884,000
55,676,000
12,618,000
12,986,000
12,976,000
9,148,000
8,888,000
2,900,000
total long term liabilities
156,480,000
196,614,000
180,425,000
197,709,000
114,630,000
59,687,000
74,286,000
91,197,000
88,422,000
25,673,000
27,374,000
26,733,000
24,299,000
24,339,000
28,723,000
total liabilities
197,050,000
243,636,000
221,002,000
227,895,000
138,836,000
151,410,000
135,675,000
141,474,000
120,177,000
37,088,000
42,269,000
48,778,000
38,158,000
41,317,000
40,170,000
net assets
217,873,000
265,517,000
282,486,000
280,958,000
274,180,000
252,199,000
203,108,000
179,263,000
162,442,000
70,780,000
64,668,000
51,848,000
44,128,000
36,081,000
16,630,000
total shareholders funds
217,873,000
265,517,000
282,486,000
280,958,000
274,180,000
252,199,000
203,108,000
179,263,000
162,442,000
70,780,000
64,668,000
51,848,000
44,128,000
36,081,000
16,630,000
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
-38,442,000
-17,689,000
21,575,000
16,316,000
35,629,000
23,667,000
30,177,000
25,610,000
16,962,000
11,171,000
13,312,000
12,320,000
12,339,000
16,974,000
11,257,000
Depreciation
1,225,000
1,558,000
1,575,000
1,753,000
1,496,000
1,335,000
1,111,000
337,000
239,000
307,000
266,000
178,000
263,000
178,000
124,000
Amortisation
9,101,000
9,202,000
8,530,000
12,057,000
179,000
211,000
276,000
92,000
199,000
1,110,000
422,000
573,000
735,000
812,000
Tax
15,664,000
1,842,000
-10,838,000
-4,989,000
-6,066,000
-4,447,000
541,000
-4,127,000
-2,490,000
-1,772,000
-2,425,000
-2,119,000
-2,076,000
-3,918,000
-1,633,000
Stock
1,425,000
3,211,000
-1,842,000
3,828,000
383,000
4,458,000
-1,108,000
2,446,000
6,996,000
446,000
75,000
-259,000
1,108,000
1,572,000
2,972,000
Debtors
5,739,000
19,311,000
6,783,000
-5,443,000
4,230,000
5,453,000
-4,473,000
16,538,000
3,308,000
-2,319,000
496,000
1,485,000
-1,030,000
2,033,000
7,657,000
Creditors
-342,000
10,226,000
-2,934,000
4,305,000
-2,008,000
2,316,000
1,007,000
4,502,000
-540,000
575,000
216,000
-292,000
-2,605,000
2,109,000
1,690,000
Accruals and Deferred Income
-6,678,000
-3,938,000
13,848,000
1,721,000
2,448,000
2,066,000
-4,121,000
6,018,000
2,973,000
-4,055,000
-4,011,000
6,478,000
-763,000
3,218,000
5,960,000
Deferred Taxes & Provisions
-43,184,000
-4,546,000
11,094,000
52,742,000
2,294,000
3,486,000
-9,044,000
7,208,000
43,058,000
-368,000
10,000
3,828,000
260,000
5,988,000
2,900,000
Cash flow from operations
-69,820,000
-25,867,000
37,909,000
85,520,000
29,359,000
18,723,000
25,528,000
20,656,000
50,097,000
8,841,000
7,219,000
19,740,000
8,075,000
21,756,000
9,669,000
Investing Activities
capital expenditure
81,987,000
7,815,000
-2,716,000
-103,155,000
-1,221,000
-56,752,000
-19,589,000
-17,033,000
-163,090,000
-3,474,000
-10,375,000
-14,310,000
-6,718,000
-17,098,000
-45,191,000
Change in Investments
60,000
17,000
-1,808,000
1,808,000
-2,945,000
1,481,000
-1,463,000
194,000
295,000
2,438,000
cash flow from investments
81,927,000
7,798,000
-2,716,000
-101,347,000
-3,029,000
-53,807,000
-21,070,000
-15,570,000
-163,284,000
-3,769,000
-12,813,000
-14,310,000
-6,718,000
-17,098,000
-45,191,000
Financing Activities
Bank loans
-41,719,000
15,937,000
10,006,000
12,881,000
-3,355,000
2,000,000
250,000
886,000
3,114,000
Group/Directors Accounts
Other Short Term Loans
413,000
-15,000
15,000
-500,000
-232,000
-2,290,000
-2,004,000
5,026,000
Long term loans
-38,425,000
30,516,000
-39,684,000
114,966,000
100,407,000
-22,340,000
-31,869,000
-2,564,000
79,457,000
-3,163,000
1,312,000
5,540,000
75,000
-18,700,000
53,535,000
Hire Purchase and Lease Commitments
155,000
-2,269,000
1,918,000
-2,058,000
603,000
1,840,000
579,000
-1,000
1,000
other long term liabilities
-215,000
3,204,000
-2,989,000
-775,000
3,595,000
-5,143,000
3,706,000
321,000
1,496,000
-20,000
-20,000
-20,000
-20,000
80,000
share issue
-4,916,000
13,355,000
2,813,000
-1,249,000
4,567,000
37,081,000
744,000
3,881,000
81,613,000
125,000
5,276,000
833,000
770,000
11,566,000
12,523,000
interest
-10,358,000
-5,361,000
-3,418,000
-3,300,000
-4,553,000
-2,830,000
-3,040,000
-3,244,000
-1,832,000
-1,042,000
-1,231,000
-1,541,000
-1,598,000
-2,403,000
-2,832,000
cash flow from financing
-53,346,000
39,445,000
-41,375,000
107,599,000
104,119,000
-33,343,000
-16,233,000
6,396,000
178,641,000
-4,080,000
1,982,000
6,812,000
-524,000
-8,670,000
66,420,000
cash and cash equivalents
cash
-9,278,000
2,653,000
163,000
11,068,000
6,937,000
-291,000
3,963,000
3,992,000
1,795,000
747,000
-3,947,000
3,555,000
-910,000
885,000
1,104,000
overdraft
-68,035,000
68,035,000
-683,000
683,000
change in cash
-9,278,000
2,653,000
163,000
11,068,000
74,972,000
-68,326,000
3,963,000
3,992,000
1,795,000
747,000
-3,947,000
3,555,000
-910,000
1,568,000
421,000
alliance pharma plc Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for alliance pharma plc. Get real-time insights into alliance pharma plc's credit score, group structure and payment trends.
Perform a competitor analysis for alliance pharma plc by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other mega companies, companies in SN15 area or any other competitors across 12 key performance metrics.
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 13 charges/mortgages relating to alliance pharma plc. Currently there are 8 open charges and 5 have been satisfied in the past.
alliance pharma plc Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ALLIANCE PHARMA PLC. This can take several minutes, an email will notify you when this has completed.
alliance pharma plcCompanies House Filings - See Documents
